Maxine L. Stitzer, Ph.D.

Professor of Behavioral Biology

Education

University of California, Berkeley, CA, B.A., 1965, Psychology
University of Michigan, Ann Arbor, MI, M.S., 1969, Pharmacology
University of Michigan, Ann Arbor, MI, Ph.D., 1971, Psychology

Employment

University of Michigan, Ann Arbor, MI
Psychopharmacology Trainee, 1967-1970
Research Associate, Department of Pharmacology, 1971-1972.

Worcester Foundation for Experimental Biology, Worcester, MA
Research Associate, 1972-1974.

Francis Scott Key Medical Center (formerly Baltimore City Hospitals), Baltimore, MD
Department of Psychiatry, 1974-1976
Medical Research Chief, 1976-present.

Johns Hopkins University School of Medicine, Baltimore, MD

Assistant Professor of Behavioral Biology, Dept. of Psychiatry and Behavioral Sciences, 1974-1981
Associate Professor of Behavioral Biology, Dept. of Psychiatry and Behavioral Sciences, 1981-1992
Professor of Behavioral Biology, Dept. of Psychiatry and Behavioral Sciences, 1992-present.

Consultant

National Institute on Drug Abuse, Research Review Committee, Clinical Behavioral panel, 1977-1980.
IOM/NAS Substance Abuse Coverage Committee, 1988-1989.
UCSF Treatment Research Unit Advisory Board, 1990-1993.
AHCPR Panel for Development of Clinical Guidelines on Smoking Cessation (1994)
National Institute on Drug Abuse Treatment Research Review Committee 1996-Present

Memberships

Psychological Association
Division of Psychopharmacology and Substance Abuse; Division on Addictions
American Public Health Association
College on Problems of Drug Dependence
Society for Research on Nicotine and Tobacco

Editorial Consultant

Addictions
Drug and Alcohol Dependence
Experimental and Clinical Psychopharmacology
Psychopharmacology

Honors

Fellow APA Division of Psychopharmacology and Substance Abuse
APA Division of Psychopharmacology and Substance Abuse President, 1992-1993
College on Problems of Drug Dependence Board of Directors, 1993-1997
Society for Research on Nicotine and Tobacco: President 1997-1998
Maryland Psychological Association Award for Outstanding Contributions to Psychology

Recent Selected Publications

Stitzer, M.L., Iguchi, M.Y. and Felch, L.J. (1992) Contingent take-home incentive: Effects on drug use of methadone maintenance patients. Journal of Consulting and Clinical Psychology, 60, 927-934.

Strain, E.C., Stitzer, M.L., Liebson, I.A. & Bigelow, G.E. (1993) Dose-response effects of methadone in the treatment of opioid dependence. Annals of Internal Medicine, 119, 23-27.

Strain, E.C., Stitzer, M.L., Liebson, I.A. & Bigelow, G.E. (1993) Methadone dose and treatment outcome. Drug and Alcohol Dependence, 33, 267-275.

Kidorf, M., Stitzer, M.L., Brooner, R.K. (1994) Characteristics of methadone patients responding to take-home incentives. Behavior Therapy, 25, 109-121.

Strain, E.C., Stitzer, M.L., Liebson, I.A. and Bigelow, G.E. (1994) Comparison of buprenorphine and methadone in the treatment of opioid dependence. American Journal of Psychiatry, 151, 1025-1030.

Johnson, R.E., Eissenberg, T., Stitzer, M.L., Strain, E.C., Liebson, I.A. and Bigelow, G.E. (1995) Buprenorphine treatment of opioid dependence: clinical trial of daily versus alternative-day dosing. Drug and Alcohol Dependence, 40, 27-35.

Stitzer, M.L. and Higgins, S.T. (1995) Behavioral treatment of drug and alcohol abuse. In: Bloom, F.E. and Kupfer, D.J. (eds). Psychopharmacology: The Fourth Generation of Progress, Raven Press, Ltd, New York, pp. 1807-1819.

Eissenberg, T. Greenwald, M.K., Johnson, R.E., Liebson, I.A., Bigelow, G.E. Stitzer, M.L. (1995) Buprenorphine's physical dependence potential: Antagonist-precipitated withdrawal in humans. Journal of Pharmacology and Experimental Therapeutics, 276, 449-459.

Greenwald, M.K., June, H.L., Stitzer, M.L. & Marco, A.P. (1996) Comparative clinical pharmacology of short-acting mu opioids in drug abusers. Journal of Pharmacology and Experimental Therapeutics, 277, 1228-1236.

Schuh, K.J., Walsh, S.L., Bigelow, G.E., Preston, K.L. & Stitzer, M.L. (1996) Buprenorphine, morphine and naloxone effects during ascending morphine maintenance in humans. Journal of Pharmacology and Experimental Therapeutics, 278, 836-846.

Clemmey, P., Brooner, R., Chutuape, M.A., Kidorf, M., Stitzer, M.L. (1997) Smoking habits and attitudes in a methadone maintenance treatment population. Drug and Alcohol Dependence, 44, 123-132.

Stitzer, M.L. and Walsh, S.L. (1997) Psychostimulant abuse: The case for combined behavioral and pharmacological treatments. Pharmacology, Biochemistry & Behavior, 57, 457-470.

Eissenberg, T., Johnson, R.E., Bigelow, G.E., Walsh, S.L., Liebson, I.A., Strain, E.C., Stitzer, M.L. (1997) Controlled opioid withdrawal evaluation during 72 h dose omission in buprenorphine-maintained patients. Drug and Alcohol Dependence, 45, 81-91.

Chutuape, M.A., Brooner, R.K., Stitzer, M.L. (1997) Sedative use disorders in opiate-dependent patients: Association with psychiatric and other substance use disorders. Journal of Nervous and Mental Disease, 185, 289-297.

Greenwald, M.K., Stitzer, M.L., Haberny, K.A. (1997) Human pharmacology of the opioid neuropeptide dynorphin A(1-13). Journal of Pharmacology and Experimental Therapeutics, 281, 1154-1163.

Eissenberg, T., Bigelow, G.E., Strain, E.C., Walsh, S.L., Brooner, R.K., Stitzer, M.L., Johnson, R.E. (1997) Dose-related efficacy of levomethadyl acetate for treatment of opioid dependence. Journal of the American Medical Association, 277, 1945-1951.

Svikis, D.S., Lee, J.H., Haug, N.A., Stitzer, M.L. (1997) Attendance incentives for outpatient treatment: effects in methadone-and nonmethadone-maintained pregnant drug dependent women. Drug and Alcohol Dependence, 48, 33-41.

Houtsmuller, E.J., Walsh, S.L., Schuh, K.J., Johnson, R.E., Stitzer, M.L., Bigelow, G.E. (1998) Dose-response analysis of opioid cross-tolerance and withdrawal suppression during LAAM maintenance. Journal of Pharmacology and Experimental Therapeutics, 285: 387-396.

Strain, E.C., Stitzer, M.L., Liebson, I.A., Bigelow, G.E. (1998) Useful predictors of outcome in methadone-treated patients: Results from a controlled clinical trial with three doses of methadone. Journal of Maintenance in the Addictions, 1, 15-28.

Jones, H.E., Strain, E.C., Bigelow, G.E., Walsh, S.L., Stitzer, M.L., Eissenberg, T., Johnson, R.E. (1998) Induction with levomethadyl acetate. Archives of General Psychiatry, 55, 729-736.

Carpenter, M.J., Chutuape, M.A., Stitzer, M.L. (1998) Heroin snorters versus injectors: comparison on drug use and treatment outcome in age-matched samples. Drug and Alcohol Dependence, 53, 11-15.

Strain, E.C. and Stitzer, M.L., eds, (in press) The Treatment of Opioid Dependence: Methadone and Alternative Medications. Johns Hopkins University Press.


E-mail contact: mstitzer@jhmi.edu

Updated: 8/8/2000
http://bpru.med.jhu.edu/bio/stitzer.html